✦ LIBER ✦

Prevention of cisplatin-induced delayed emesis: still unsatisfactory

✍ Scribed by Italian Group for Antiemetic Research; F. Roila

Book ID: 106175068
Publisher: Springer-Verlag
Year: 2000
Tongue: English
Weight: 66 KB
Volume: 8
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s005200050290

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisapride and dexamethasone in the preve

Cisapride and dexamethasone in the prevention of delayed emesis after cisplatin administration

✍ Roberto Maisano; Pietro Spadaro; Giuseppe Toscano; Nicola Caristi; Stefano Pergo 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 110 KB

Serotonin 5-HT3receptor antagonists prev

Serotonin 5-HT3receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis

✍ N. A. Darmani 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 120 KB

Double-blind, randomized crossover study

Double-blind, randomized crossover study of metoclopramide and batanopride for prevention of cisplatin-induced emesis

✍ Gini F. Fleming; Everett E. Vokes; Jan-Marie McEvilly; Linda Janisch; Donna Fran 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 227 KB

Aetiology and prevention of emesis induc

Aetiology and prevention of emesis induced by radiotherapy

✍ P. C. Feyer; Alan L. Stewart; Otto J. Titlbach 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 178 KB

Chemotherapy-induced emesis: management

Chemotherapy-induced emesis: management of early and delayed emesis in milder emetogenic regimens

✍ G. Barrenetxea; José Schneider; María Mar Centeno; Hernando Romero; Matxalen de 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 461 KB

Prevention of cisplatin-induced acute an

Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869 : A randomized controlled trial

✍ Simon Van Belle; Michael R. Lichinitser; Rudolph M. Navari; August M. Garin; Mar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

## Abstract ## BACKGROUND Recent studies have suggested that antiemetic therapy with a triple combination of the neurokinin‐1 receptor antagonist MK‐869, a serotonin (5‐HT~3~) antagonist, and dexamethasone provides enhanced control of cisplatin‐induced emesis compared with standard therapy regimen